John Emanuel Markis, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Streptokinase | 6 | 1986 | 186 | 0.160 |
Why?
|
| Tissue Plasminogen Activator | 8 | 1988 | 1164 | 0.160 |
Why?
|
| Thallium | 4 | 1987 | 100 | 0.110 |
Why?
|
| Coronary Circulation | 8 | 1987 | 1569 | 0.110 |
Why?
|
| Radioisotopes | 4 | 1987 | 499 | 0.100 |
Why?
|
| Angina Pectoris | 5 | 1979 | 959 | 0.080 |
Why?
|
| Myocardial Infarction | 13 | 1988 | 11461 | 0.070 |
Why?
|
| Pulmonary Embolism | 7 | 1988 | 2567 | 0.070 |
Why?
|
| Fibrinolytic Agents | 6 | 1988 | 2084 | 0.060 |
Why?
|
| Prostaglandins E | 1 | 1981 | 166 | 0.050 |
Why?
|
| Coronary Disease | 9 | 1982 | 5914 | 0.050 |
Why?
|
| Radionuclide Imaging | 8 | 1988 | 1972 | 0.040 |
Why?
|
| Cineangiography | 3 | 1987 | 108 | 0.040 |
Why?
|
| Isosorbide Dinitrate | 1 | 1979 | 34 | 0.040 |
Why?
|
| Isoproterenol | 2 | 1996 | 395 | 0.040 |
Why?
|
| Myocardial Contraction | 3 | 1996 | 1515 | 0.040 |
Why?
|
| Strophanthidin | 1 | 1996 | 15 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1996 | 100 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1981 | 774 | 0.030 |
Why?
|
| Physical Exertion | 1 | 1979 | 667 | 0.030 |
Why?
|
| Heart | 6 | 1988 | 4404 | 0.030 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1996 | 214 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1996 | 539 | 0.030 |
Why?
|
| Coronary Angiography | 7 | 1987 | 4471 | 0.030 |
Why?
|
| Coronary Vessels | 9 | 1988 | 3096 | 0.030 |
Why?
|
| Recombinant Proteins | 5 | 1988 | 6534 | 0.030 |
Why?
|
| Bretylium Compounds | 1 | 1971 | 7 | 0.020 |
Why?
|
| Reflex | 2 | 1984 | 376 | 0.020 |
Why?
|
| Echocardiography | 6 | 1987 | 4989 | 0.020 |
Why?
|
| Pyridones | 1 | 1996 | 809 | 0.020 |
Why?
|
| Acute Disease | 5 | 1988 | 7237 | 0.020 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1996 | 1241 | 0.020 |
Why?
|
| Pulmonary Circulation | 3 | 1988 | 737 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 1988 | 325 | 0.020 |
Why?
|
| Drug Evaluation | 3 | 1981 | 641 | 0.020 |
Why?
|
| Heart Ventricles | 7 | 1988 | 3807 | 0.020 |
Why?
|
| Nitroglycerin | 3 | 1981 | 329 | 0.020 |
Why?
|
| Radiography | 5 | 1988 | 6965 | 0.020 |
Why?
|
| Cardiac Output, Low | 1 | 1987 | 191 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 1971 | 1201 | 0.020 |
Why?
|
| Heart Rate | 3 | 1983 | 4195 | 0.020 |
Why?
|
| Cardiomegaly | 1 | 1987 | 590 | 0.010 |
Why?
|
| Time Factors | 8 | 1988 | 39969 | 0.010 |
Why?
|
| Angiocardiography | 3 | 1979 | 149 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1985 | 411 | 0.010 |
Why?
|
| Clinical Trials as Topic | 6 | 1988 | 8002 | 0.010 |
Why?
|
| Collateral Circulation | 3 | 1980 | 294 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1985 | 416 | 0.010 |
Why?
|
| Blood Pressure | 6 | 1983 | 8481 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1985 | 685 | 0.010 |
Why?
|
| Heart Conduction System | 2 | 1979 | 1007 | 0.010 |
Why?
|
| Electrocardiography | 3 | 1985 | 6377 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1987 | 2217 | 0.010 |
Why?
|
| Angina Pectoris, Variant | 2 | 1981 | 53 | 0.010 |
Why?
|
| Hemodynamics | 3 | 1987 | 4160 | 0.010 |
Why?
|
| Bioprosthesis | 1 | 1987 | 591 | 0.010 |
Why?
|
| Pulmonary Artery | 4 | 1988 | 1927 | 0.010 |
Why?
|
| Adult | 24 | 1996 | 221210 | 0.010 |
Why?
|
| Propranolol | 2 | 1980 | 489 | 0.010 |
Why?
|
| Myocardium | 3 | 1985 | 4725 | 0.010 |
Why?
|
| Myxoma | 1 | 1981 | 114 | 0.010 |
Why?
|
| Middle Aged | 21 | 1996 | 220921 | 0.010 |
Why?
|
| Dilatation, Pathologic | 2 | 1988 | 527 | 0.010 |
Why?
|
| Cardiac Output | 2 | 1980 | 831 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 2 | 1987 | 1462 | 0.010 |
Why?
|
| Perfusion | 1 | 1984 | 1373 | 0.010 |
Why?
|
| Assisted Circulation | 1 | 1979 | 100 | 0.010 |
Why?
|
| Cardiac Complexes, Premature | 1 | 1978 | 63 | 0.010 |
Why?
|
| Humans | 41 | 1996 | 761596 | 0.010 |
Why?
|
| Ferricyanides | 1 | 1978 | 31 | 0.010 |
Why?
|
| Ventricular Fibrillation | 1 | 1981 | 537 | 0.010 |
Why?
|
| Aged | 17 | 1988 | 169310 | 0.010 |
Why?
|
| Spasm | 1 | 1978 | 130 | 0.010 |
Why?
|
| Heart Neoplasms | 1 | 1981 | 362 | 0.010 |
Why?
|
| Nitroprusside | 1 | 1978 | 272 | 0.010 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1979 | 223 | 0.010 |
Why?
|
| Esophageal Diseases | 1 | 1978 | 168 | 0.010 |
Why?
|
| Thrombosis | 2 | 1981 | 2942 | 0.010 |
Why?
|
| Male | 23 | 1988 | 360846 | 0.010 |
Why?
|
| Cardiac Tamponade | 1 | 1978 | 175 | 0.010 |
Why?
|
| Milrinone | 1 | 1996 | 86 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1996 | 531 | 0.010 |
Why?
|
| Stimulation, Chemical | 2 | 1977 | 306 | 0.010 |
Why?
|
| Coronary Artery Bypass | 3 | 1981 | 2188 | 0.010 |
Why?
|
| Female | 22 | 1988 | 392705 | 0.010 |
Why?
|
| Mediastinal Neoplasms | 1 | 1978 | 401 | 0.010 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 1978 | 866 | 0.010 |
Why?
|
| Placebos | 1 | 1979 | 1667 | 0.010 |
Why?
|
| Fibrinogen | 2 | 1988 | 888 | 0.010 |
Why?
|
| Papillary Muscles | 2 | 1972 | 192 | 0.010 |
Why?
|
| Administration, Oral | 2 | 1979 | 4021 | 0.010 |
Why?
|
| Heart Atria | 3 | 1981 | 1345 | 0.010 |
Why?
|
| Cats | 2 | 1972 | 975 | 0.010 |
Why?
|
| Follow-Up Studies | 4 | 1987 | 39106 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 1987 | 273 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1974 | 554 | 0.010 |
Why?
|
| Cardiac Glycosides | 1 | 1972 | 29 | 0.010 |
Why?
|
| Postoperative Complications | 3 | 1987 | 15633 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1977 | 1736 | 0.010 |
Why?
|
| Heart Failure | 1 | 1996 | 11671 | 0.010 |
Why?
|
| Receptors, Drug | 1 | 1972 | 157 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1986 | 3424 | 0.010 |
Why?
|
| Reserpine | 1 | 1971 | 63 | 0.010 |
Why?
|
| Tyramine | 1 | 1971 | 53 | 0.010 |
Why?
|
| Fatigue | 1 | 1979 | 1552 | 0.010 |
Why?
|
| Nerve Endings | 1 | 1971 | 105 | 0.010 |
Why?
|
| Exercise Test | 1 | 1979 | 2127 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1971 | 1310 | 0.010 |
Why?
|
| Mitral Valve | 3 | 1987 | 1465 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1978 | 1310 | 0.010 |
Why?
|
| Reference Values | 1 | 1996 | 4920 | 0.010 |
Why?
|
| Lung | 1 | 1988 | 10002 | 0.010 |
Why?
|
| Models, Structural | 2 | 1983 | 340 | 0.000 |
Why?
|
| Lung Diseases | 1 | 1979 | 1909 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1971 | 897 | 0.000 |
Why?
|
| Heart Diseases | 1 | 1981 | 2781 | 0.000 |
Why?
|
| Sympathetic Nervous System | 1 | 1971 | 518 | 0.000 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 1988 | 66 | 0.000 |
Why?
|
| Prospective Studies | 2 | 1987 | 54423 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1996 | 6228 | 0.000 |
Why?
|
| Pericardial Effusion | 2 | 1980 | 247 | 0.000 |
Why?
|
| Sarcoma | 1 | 1978 | 1801 | 0.000 |
Why?
|
| Heart Septum | 1 | 1987 | 301 | 0.000 |
Why?
|
| Skin Manifestations | 1 | 1965 | 17 | 0.000 |
Why?
|
| Fibrin | 1 | 1988 | 507 | 0.000 |
Why?
|
| Cardiac Volume | 1 | 1986 | 197 | 0.000 |
Why?
|
| Pharmaceutical Preparations | 1 | 1974 | 1089 | 0.000 |
Why?
|
| Werner Syndrome | 1 | 1965 | 12 | 0.000 |
Why?
|
| Injections, Intra-Arterial | 1 | 1985 | 182 | 0.000 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 1987 | 422 | 0.000 |
Why?
|
| Double-Blind Method | 1 | 1979 | 12341 | 0.000 |
Why?
|
| Diagnosis | 1 | 1965 | 157 | 0.000 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1996 | 10766 | 0.000 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 1987 | 451 | 0.000 |
Why?
|
| Random Allocation | 1 | 1988 | 2395 | 0.000 |
Why?
|
| Progeria | 1 | 1965 | 188 | 0.000 |
Why?
|
| Heart Transplantation | 1 | 1996 | 3233 | 0.000 |
Why?
|
| Smoking | 1 | 1978 | 9053 | 0.000 |
Why?
|
| Angiography | 1 | 1987 | 1595 | 0.000 |
Why?
|
| Prognosis | 2 | 1985 | 29629 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1985 | 1687 | 0.000 |
Why?
|
| Computers | 1 | 1983 | 593 | 0.000 |
Why?
|
| Heparin | 1 | 1987 | 1634 | 0.000 |
Why?
|
| Phonocardiography | 1 | 1978 | 30 | 0.000 |
Why?
|
| Cataract | 1 | 1965 | 832 | 0.000 |
Why?
|
| Pulse | 1 | 1978 | 217 | 0.000 |
Why?
|
| Rupture | 1 | 1979 | 443 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1978 | 1625 | 0.000 |
Why?
|
| Vascular Resistance | 1 | 1978 | 930 | 0.000 |
Why?
|
| Absorption | 1 | 1974 | 242 | 0.000 |
Why?
|
| Carotid Arteries | 1 | 1978 | 941 | 0.000 |
Why?
|
| Atropine | 1 | 1974 | 244 | 0.000 |
Why?
|
| Stroke Volume | 1 | 1988 | 5496 | 0.000 |
Why?
|
| Regression Analysis | 1 | 1983 | 6345 | 0.000 |
Why?
|
| Nicotine | 1 | 1978 | 680 | 0.000 |
Why?
|
| Streptomyces griseus | 1 | 1972 | 5 | 0.000 |
Why?
|
| Lipoproteins | 1 | 1978 | 881 | 0.000 |
Why?
|
| Oximes | 1 | 1974 | 303 | 0.000 |
Why?
|
| Rubidium | 1 | 1972 | 122 | 0.000 |
Why?
|
| Microsomes | 1 | 1972 | 251 | 0.000 |
Why?
|
| Myoglobin | 1 | 1972 | 159 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1972 | 646 | 0.000 |
Why?
|
| Serum Albumin, Bovine | 1 | 1972 | 321 | 0.000 |
Why?
|
| Adolescent | 2 | 1978 | 88326 | 0.000 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1981 | 2244 | 0.000 |
Why?
|
| Digoxin | 1 | 1972 | 246 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1978 | 1779 | 0.000 |
Why?
|
| Animals | 4 | 1981 | 168475 | 0.000 |
Why?
|
| Dogs | 1 | 1974 | 3839 | 0.000 |
Why?
|
| Peptide Hydrolases | 1 | 1972 | 624 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1972 | 672 | 0.000 |
Why?
|
| Potassium | 1 | 1972 | 1311 | 0.000 |
Why?
|
| Adenosine Triphosphatases | 1 | 1972 | 836 | 0.000 |
Why?
|
| Sodium | 1 | 1972 | 1588 | 0.000 |
Why?
|
| Kinetics | 1 | 1974 | 6374 | 0.000 |
Why?
|
| Enzyme Activation | 1 | 1972 | 3597 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1972 | 2413 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1978 | 12973 | 0.000 |
Why?
|
| Contrast Media | 1 | 1974 | 5307 | 0.000 |
Why?
|
| Peptides | 1 | 1972 | 4358 | 0.000 |
Why?
|